Статті в журналах з теми "Highly Upregulated in Liver Carcinoma"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Highly Upregulated in Liver Carcinoma".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Wadkin, James C. R., Daniel A. Patten, Sivesh K. Kamarajah, Emma L. Shepherd, Vera Novitskaya, Fedor Berditchevski, David H. Adams, Chris J. Weston, and Shishir Shetty. "CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma." American Journal of Physiology-Gastrointestinal and Liver Physiology 313, no. 2 (August 1, 2017): G138—G149. http://dx.doi.org/10.1152/ajpgi.00411.2016.
Повний текст джерелаJiang, Xue, and Weiwei Liu. "Long Noncoding RNA Highly Upregulated in Liver Cancer Activates p53-p21 Pathway and Promotes Nasopharyngeal Carcinoma Cell Growth." DNA and Cell Biology 36, no. 7 (July 2017): 596–602. http://dx.doi.org/10.1089/dna.2017.3686.
Повний текст джерелаYang, Shuang, Jian Zhou, Weiwu Gao, Xia Yang, Di Yang, Zhiqiang Tian, Yuzhang Wu, Mengjie Zhang, Yi Zhang, and Bing Ni. "Multifunctional YY1 in Liver Diseases." Seminars in Liver Disease 37, no. 04 (November 2017): 363–76. http://dx.doi.org/10.1055/s-0037-1607451.
Повний текст джерелаHenderson, James M., Michelle S. W. Xiang, Jiali Carrie Huang, Stefanie Wetzel, Linxuan Jiang, Jack H. Lai, Wengen Wu, et al. "Dipeptidyl Peptidase Inhibition Enhances CD8 T Cell Recruitment and Activates Intrahepatic Inflammasome in a Murine Model of Hepatocellular Carcinoma." Cancers 13, no. 21 (November 1, 2021): 5495. http://dx.doi.org/10.3390/cancers13215495.
Повний текст джерелаRuan, Lingjuan, Lifei Huang, Lilai Zhao, Qiang Wang, Xiaocheng Pan, Anmin Zhang, Qiuping Bai, and Zongjun Lv. "The Interaction of lncRNA-HEIH and lncRNA-HULC with HBXIP in Hepatitis B Patients." Gastroenterology Research and Practice 2018 (December 4, 2018): 1–6. http://dx.doi.org/10.1155/2018/9187316.
Повний текст джерелаHuynh, Kenneth N., Sriram Rao, Bradley Roth, Theodore Bryan, Dayantha M. Fernando, Farshid Dayyani, David Imagawa та Nadine Abi-Jaoudeh. "Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma". Cancers 15, № 10 (12 травня 2023): 2738. http://dx.doi.org/10.3390/cancers15102738.
Повний текст джерелаLi, Duguang, Junhai Pan, Yiyin Zhang, Yirun Li, Shengxi Jin, Cheng Zhong, Peng Chen, et al. "C8orf76 Modulates Ferroptosis in Liver Cancer via Transcriptionally Up-Regulating SLC7A11." Cancers 14, no. 14 (July 13, 2022): 3410. http://dx.doi.org/10.3390/cancers14143410.
Повний текст джерелаKim, Wantae, Sanjoy Kumar Khan, Yuchen Liu, Ruoshi Xu, Ogyi Park, Yong He, Boksik Cha, Bin Gao, and Yingzi Yang. "Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma." Gut 67, no. 9 (September 2, 2017): 1692–703. http://dx.doi.org/10.1136/gutjnl-2017-314061.
Повний текст джерелаCorreia de Sousa, Marta, Nicolas Calo, Cyril Sobolewski, Monika Gjorgjieva, Sophie Clément, Christine Maeder, Dobrochna Dolicka, et al. "Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis." Cancers 13, no. 19 (October 4, 2021): 4983. http://dx.doi.org/10.3390/cancers13194983.
Повний текст джерелаXie, Hui, Hongwei Ma, and Danqiu Zhou. "Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma." BioMed Research International 2013 (2013): 1–5. http://dx.doi.org/10.1155/2013/136106.
Повний текст джерелаLiu, Zhenrong, Yaru Wang, Zulihumaer Aizimuaji, Sheng Ma, and Ting Xiao. "Elevated FOXA1 Expression Indicates Poor Prognosis in Liver Cancer due to Its Effects on Cell Proliferation and Metastasis." Disease Markers 2022 (August 5, 2022): 1–16. http://dx.doi.org/10.1155/2022/3317315.
Повний текст джерелаHan, Sanfeng, Tao Ye, Yuqin Mao, Bo Hu, and Chen Wang. "Cuproptosis-Related Genes CDK1 and COA6 Involved in the Prognosis Prediction of Liver Hepatocellular Carcinoma." Disease Markers 2023 (May 11, 2023): 1–17. http://dx.doi.org/10.1155/2023/5552798.
Повний текст джерелаLopez, Samantha, Adithya Anilkumar, Kyle Doxtater, Sudhir Kotnala, Neeraj Chauhan, Murali Yallapu, Meena Jaggi, Subhash Chauhan, and Manish Tripathi. "Abstract 544: Role of an ankyrin domain protein in hepatocellular carcinoma progression." Cancer Research 82, no. 12_Supplement (June 15, 2022): 544. http://dx.doi.org/10.1158/1538-7445.am2022-544.
Повний текст джерелаLiu, Kairui, Xiaolin Wu, Xian Zang, Zejian Huang, Zeyu Lin, Wenliang Tan, Xiang Wu, Wenrou Hu, Baoqi Li, and Lei Zhang. "Erratum." Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28, no. 5 (December 10, 2020): 559–60. http://dx.doi.org/10.3727/096504020x16032056440102.
Повний текст джерелаSuzuki-Kemuriyama, Noriko, Akari Abe, Sae Nakane, Megumi Yuki, Katsuhiro Miyajima, and Dai Nakae. "Nonalcoholic steatohepatitis-associated hepatocarcinogenesis in mice fed a modified choline-deficient, methionine-lowered, L-amino acid-defined diet and the role of signal changes." PLOS ONE 18, no. 8 (August 3, 2023): e0287657. http://dx.doi.org/10.1371/journal.pone.0287657.
Повний текст джерелаLu, I.-Ta, Shih-Chao Lin, Yi-Chia Chu, Ya Wen, You-Cheng Lin, Wen-Chien Cheng, Jyh-Horng Sheu, and Chi-Chien Lin. "(−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma." Marine Drugs 20, no. 2 (January 29, 2022): 109. http://dx.doi.org/10.3390/md20020109.
Повний текст джерелаKrizanac, Marinela, Paola Berenice Mass Sanchez, Sarah K. Schröder, Ralf Weiskirchen, and Anastasia Asimakopoulos. "Lipid-Independent Regulation of PLIN5 via IL-6 through the JAK/STAT3 Axis in Hep3B Cells." International Journal of Molecular Sciences 24, no. 8 (April 13, 2023): 7219. http://dx.doi.org/10.3390/ijms24087219.
Повний текст джерелаWu, Hao, Zhixin Zhang, Xinyu Han, Sai Zhang, Jinrui Zhang, Pinsheng Han, Youcheng Zhang, Yi Bai, and Yamin Zhang. "Upregulated SSB Is Involved in Hepatocellular Carcinoma Progression and Metastasis through the Epithelial-Mesenchymal Transition, Antiapoptosis, and Altered ROS Level Pathway." Oxidative Medicine and Cellular Longevity 2023 (February 4, 2023): 1–16. http://dx.doi.org/10.1155/2023/5207431.
Повний текст джерелаGouthamchandra, K., Anuj Kumar, Shivaprasad Shwetha, Anirban Mukherjee, Madhavi Chandra, B. Ravishankar, M. N. Khaja, Provash Chandra Sadhukhan, and Saumitra Das. "Serum proteomics of hepatitis C virus infection reveals retinol-binding protein 4 as a novel regulator." Journal of General Virology 95, no. 8 (August 1, 2014): 1654–67. http://dx.doi.org/10.1099/vir.0.062430-0.
Повний текст джерелаLi, Jiahao, Lansi Chen, Jingjing Pang, Chunxiu Yang, Wen Xie, Guoyan Shen, Hongshan Chen, Xiaoyi Li, Shu-Yuan Xiao, and Yueying Li. "Autophagy-Related Gene WD Repeat Domain 45B Promotes Tumor Proliferation and Migration of Hepatocellular Carcinoma through the Akt/mTOR Signaling Pathway." Diagnostics 13, no. 5 (February 27, 2023): 906. http://dx.doi.org/10.3390/diagnostics13050906.
Повний текст джерелаÖnlen Güneri, Cansu, Hamza Malik Okuyan, Gülay Gülbol Duran, and Mehmet Demir. "Investigation of LncRNAs expression in patients with hepatitis B virus." Journal of Clinical Medicine of Kazakhstan 19, no. 6 (December 30, 2022): 27–31. http://dx.doi.org/10.23950/jcmk/12662.
Повний текст джерелаWang, Gang, Xuefeng Li, Hongyan Jia, Lei Zhang, Yang Li, Qiuxue Zhang, and Meng Lu. "Curcumin nanocarrier carrying si-TAR-RNA binding protein (TRBP) restricts development of hepatocellular carcinoma." Materials Express 13, no. 3 (March 1, 2023): 407–13. http://dx.doi.org/10.1166/mex.2023.2368.
Повний текст джерелаKitab, Bouchra, and Kyoko Tsukiyama-Kohara. "Regulatory Role of Ribonucleotide Reductase Subunit M2 in Hepatocyte Growth and Pathogenesis of Hepatitis C Virus." International Journal of Molecular Sciences 24, no. 3 (January 30, 2023): 2619. http://dx.doi.org/10.3390/ijms24032619.
Повний текст джерелаKhan, Walizeb, Washaakh Ahmad, Anwar M. Hashem, Shadi Zakai, Shafiul Haque, Muhammad Faraz Arshad Malik, Steve Harakeh, and Farhan Haq. "Genomic Relevance of FGFR2 on the Prognosis of HCV-Induced Hepatocellular Carcinoma Patients." Journal of Clinical Medicine 11, no. 11 (May 30, 2022): 3093. http://dx.doi.org/10.3390/jcm11113093.
Повний текст джерелаTao, Hanchuan, Cheng Wang, Chongmei Lu, Ning Ma, Yifan Zhu, Shihai Xuan, and Xiaojun Zhou. "Comprehensive Analysis on the Specific Role and Function of Mitochondrial Inner Membrane Protein MPV17 in Liver Hepatocellular Carcinoma." Genetics Research 2022 (July 19, 2022): 1–14. http://dx.doi.org/10.1155/2022/7236823.
Повний текст джерелаLi, Jianguo, Jin Zhou, Shuangshuang Kai, Can Wang, Daijun Wang, and Jiying Jiang. "Network-Based Coexpression Analysis Identifies Functional and Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma." BioMed Research International 2020 (October 6, 2020): 1–11. http://dx.doi.org/10.1155/2020/1371632.
Повний текст джерелаLi, Ru, Hikari Okada, Taro Yamashita, Kouki Nio, Han Chen, Yingyi Li, Tetsuro Shimakami, et al. "FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition." International Journal of Molecular Sciences 23, no. 15 (July 27, 2022): 8305. http://dx.doi.org/10.3390/ijms23158305.
Повний текст джерелаOng, Jiann Ruey, Oluwaseun Adebayo Bamodu, Nguyen Viet Khang, Yen-Kuang Lin, Chi-Tai Yeh, Wei-Hwa Lee, and Yih-Giun Cherng. "SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic Cancer Metabolism Biomarker of Hepatocellular Carcinoma." Cells 10, no. 1 (January 17, 2021): 178. http://dx.doi.org/10.3390/cells10010178.
Повний текст джерелаJang, Jeong Won, Ji Min Kim, Hye Seon Kim, Jin Seoub Kim, Ji Won Han, Soon Kyu Lee, Heechul Nam, et al. "Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma." Journal of Liver Cancer 22, no. 1 (March 31, 2022): 30–39. http://dx.doi.org/10.17998/jlc.2022.02.25.
Повний текст джерелаYang, Yi, Ming Yang, Huasheng Pang, Yiwen Qiu, Ting Sun, Tao Wang, Shu Shen, and Wentao Wang. "A Macrophage Differentiation-Mediated Gene: DDX20 as a Molecular Biomarker Encompassing the Tumor Microenvironment, Disease Staging, and Prognoses in Hepatocellular Carcinoma." Oxidative Medicine and Cellular Longevity 2022 (October 5, 2022): 1–22. http://dx.doi.org/10.1155/2022/9971776.
Повний текст джерелаPaslaru, Liliana, Gabriela Bindea, Anca Nastase, Andrei Sorop, Cristian Zimbru, Vlad Herlea, Doina Hrehoret, et al. "Comparative RNA-Sequencing Analysis Reveals High Complexity and Heterogeneity of Transcriptomic and Immune Profiles in Hepatocellular Carcinoma Tumors of Viral (HBV, HCV) and Non-Viral Etiology." Medicina 58, no. 12 (December 7, 2022): 1803. http://dx.doi.org/10.3390/medicina58121803.
Повний текст джерелаPár, Alajos, and Gabriella Pár. "Alkoholos májbetegség: a genetikai-epigenetikai tényezők szerepe és az absztinencia hatása." Orvosi Hetilap 160, no. 14 (April 2019): 524–32. http://dx.doi.org/10.1556/650.2019.31352.
Повний текст джерелаYuan, Hongchao, Yuanjun Lu, Yau-Tuen Chan, Cheng Zhang, Ning Wang, and Yibin Feng. "The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development." Cancers 13, no. 22 (November 14, 2021): 5700. http://dx.doi.org/10.3390/cancers13225700.
Повний текст джерелаLi, Yaqun, Wenhuan Fu, Zikai Geng, Yun Song, Xionggang Yang, Tianye He, Jian Wu, and Bin Wang. "A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors." PeerJ 10 (November 28, 2022): e14432. http://dx.doi.org/10.7717/peerj.14432.
Повний текст джерелаHuang, Shuai, Xiangkun Wang, Kai Luo, Xudong Zhang, Zhongyuan Liu, and Renfeng Li. "Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System Tumors." Oxidative Medicine and Cellular Longevity 2022 (September 20, 2022): 1–20. http://dx.doi.org/10.1155/2022/1129062.
Повний текст джерелаFang, Xiaona, Shan Liu, Liuxian Ban, Jiao Huang, Jie Luo, Lanqi Gong, Baifeng Zhang, et al. "Abstract 2441: Identification and characterization of the role of KRT17 in the stemness regulation of hepatocellular carcinoma." Cancer Research 83, no. 7_Supplement (April 4, 2023): 2441. http://dx.doi.org/10.1158/1538-7445.am2023-2441.
Повний текст джерелаSakamoto, Yuzuru, Sachiyo Yoshio, Akihisa Nagatsu, Yoh Asahi, Shingo Shimada, Tatsuya Orimo, Hirofumi Kamachi, Toshiya Kamiyama, Tatsuya Kanto, and Akinobu Taketomi. "Increased frequency of PD-1+CD57+Siglec-7- dysfunctional NK cells in patients with nonalcoholic fatty liver disease." Journal of Clinical Oncology 38, no. 4_suppl (February 1, 2020): 589. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.589.
Повний текст джерелаBeaumont, Jamie, Eric Aboagye, Beata Wojciak-Stothard, Gilberto Serrano-De-Almeida, Robert Glen, and Rohini Sharma. "Abstract 5398: Apelinergic signalling in hepatocellular carcinoma (HCC): A new therapeutic treatment option." Cancer Research 82, no. 12_Supplement (June 15, 2022): 5398. http://dx.doi.org/10.1158/1538-7445.am2022-5398.
Повний текст джерелаLiu, Jun, Zheng Chen, and Wenli Li. "Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients." Journal of Oncology 2021 (March 17, 2021): 1–15. http://dx.doi.org/10.1155/2021/6676537.
Повний текст джерелаJung, Ji Hoon, Hyo-Jung Lee, Ju-Ha Kim, Deok Yong Sim, Eunji Im, Sinae Kim, Suhwan Chang, and Sung-Hoon Kim. "Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2." Cells 9, no. 4 (April 16, 2020): 985. http://dx.doi.org/10.3390/cells9040985.
Повний текст джерелаZhang, Hailong. "Abstract B031: PRC2 inhibitor suppresses angiogenesis in Hepatocellular carcinoma (HCC) by up-regulation of anti-angiogenic factors vasohibin1 (VASH1) and tissue inhibitor of metalloproteinases 3 (TIMP-3)." Cancer Research 82, no. 23_Supplement_2 (December 1, 2022): B031. http://dx.doi.org/10.1158/1538-7445.cancepi22-b031.
Повний текст джерелаVijay-Kumar, Matam, Beng San Yeoh, Vishal Singh, Rachel M. Golonka, and Piu Saha. "Dietary Soluble Fiber Induces HCC in Dysbiotic Mice Through a Spectrum of Immunosuppressive Mediators." Journal of Immunology 202, no. 1_Supplement (May 1, 2019): 59.3. http://dx.doi.org/10.4049/jimmunol.202.supp.59.3.
Повний текст джерелаDuffy, Austin G., Osama E. Rahma, Susanna Varkey Ulahannan, Suzanne Fioravanti, Aradhana Venkatesan, Ismail B. Turkbey, Peter L. Choyke, Jane B. Trepel, William Douglas Figg, and Tim F. Greten. "A phase II study of TR105 in patients with hepatocellular carcinoma (HCC) who have progressed on sorafenib." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e15177-e15177. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e15177.
Повний текст джерелаKwon, Young-Chan, Sandip K. Bose, Robert Steele, Keith Meyer, Adrian M. Di Bisceglie, Ratna B. Ray, and Ranjit Ray. "Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes." Journal of Virology 89, no. 22 (September 9, 2015): 11549–56. http://dx.doi.org/10.1128/jvi.01946-15.
Повний текст джерелаVerslype, Chris, Hannah van Malenstein, Jeroen Dekervel, Petra Windmolders, Louis Libbrecht, Rudy van Eijsden, Frederik Nevens, and Jos van Pelt. "Resistance development after long-term sorafenib exposure in hepatocellular cancer cell lines and risk of rebound growth and epithelial to mesenchymal transition." Journal of Clinical Oncology 30, no. 4_suppl (February 1, 2012): 216. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.216.
Повний текст джерелаWeinberger, Paul, Sithara Raju Ponny, Hongyan Xu, Shan Bai, Robert Smallridge, John Copland, and Ashok Sharma. "Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma." Thyroid 27, no. 2 (February 2017): 236–52. http://dx.doi.org/10.1089/thy.2016.0285.
Повний текст джерелаPaganoni, Rossana, André Lechel, and Maja Vujic Spasic. "Iron at the Interface of Hepatocellular Carcinoma." International Journal of Molecular Sciences 22, no. 8 (April 15, 2021): 4097. http://dx.doi.org/10.3390/ijms22084097.
Повний текст джерелаLiang, Zenghui, Yingtang Gao, Wenxia Shi, Daokuan Zhai, Shilei Li, Li Jing, Hua Guo, Tong Liu, Yajie Wang, and Zhi Du. "Expression and Significance of MicroRNA-183 in Hepatocellular Carcinoma." Scientific World Journal 2013 (2013): 1–6. http://dx.doi.org/10.1155/2013/381874.
Повний текст джерелаMatouk, Imad J., Ibrahim Abbasi, Abraham Hochberg, Eithan Galun, Hassan Dweik, and Mutaz Akkawi. "Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis." European Journal of Gastroenterology & Hepatology 21, no. 6 (June 2009): 688–92. http://dx.doi.org/10.1097/meg.0b013e328306a3a2.
Повний текст джерелаGhafouri‐Fard, Soudeh, Mohammadhosein Esmaeili, Mohammad Taheri, and Majid Samsami. "Highly upregulated in liver cancer (HULC): An update on its role in carcinogenesis." Journal of Cellular Physiology 235, no. 12 (May 5, 2020): 9071–79. http://dx.doi.org/10.1002/jcp.29765.
Повний текст джерела